Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of Didanosine in healthy volunteers

C. la Porte, C. Verweij-van Wissen, N. van Ewijk, R. Aarnoutse, P. Koopmans, P. Reiss, M. Stek, Y. Hekster, D. Burger

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)

Abstract

Didanosine enteric-coated should be taken on an empty stomach, but the once-daily combination of indinavir/ ritonavir can be taken with food. Because these drugs are frequently included in 1 regimen, the food effects on the pharmacokinetics were evaluated. This was a randomized, 4-way crossover study of single doses of didanosine enteric-coated 400 mg and indinavir/ritonavir 12001400 mg in 8 healthy subjects. The following regimens were given: didanosine enteric-coated 2 hours after breakfast (reference regimen A), indinavir/ritonavir with breakfast (reference regimen B), didanosine enteric-coated + indinavir/ritonavir 2 hours after breakfast (test regimen Q, and didanosine enteric-coated + indinavir/ritonavir with breakfast (test regimen D). Breakfast was 550 kcal, 28% fat. Blood samples were drawn before and up to 24 hours after ingestion, Statistical comparisons of test regimens C and D with reference regimens A and B were made using the equivalence approach for indinavir and didanosine area under the curve and C.. (0.80-1.25). Eight subjects (5 men, 3 women) were enrolled and completed the study. Indinavir area under the curves were bioequivalent in test regimens C and D compared to reference regimen B. A 14% increased C-max was observed in test regimen C. Didanosine area under the curve in test regimen D was 4 % lower and suggestive of bioequivalence compared to reference regimen A. However, test regimen C didanosine area under the curve was 23% lower and bioinequivalent compared to reference regimen A. Didanosine C.. decreased 42% and 46% in test regimens C and D, respectively, in comparison to reference regimen A. In this study, dosing didanosine enteric-coated 400 mg once daily + indinavir/ritonavir 12001400 mg once daily with breakfast indicated no decrease in the amount of absorption for either didanosine and indinavir and that this regimen could be administered with food
Original languageEnglish
Pages (from-to)211-218
JournalJournal of clinical pharmacology
Volume45
Issue number2
DOIs
Publication statusPublished - 2005

Cite this